ACCURAY WKN: A0MKWM ISIN: US0043971052 Kürzel: XEJ Forum: Aktien Thema: Hauptdiskussion
1,52 EUR
±0,00 %±0,00
4. May, 09:21:32 Uhr,
Lang & Schwarz
Kommentare 247
Summer.76,
31.01.2024 22:41 Uhr
0
https://investors.accuray.com/news-releases/news-release-details/accuray-reports-fiscal-2024-second-quarter-financial-results
Accuray Reports Fiscal 2024 Second Quarter Financial Results
19% Order Growth YOY; 8% Service Revenue Expansion; Confirms FY24 Guidance
Summer.76,
31.01.2024 22:41 Uhr
0
Accuray GAAP EPS of -$0.10 misses by $0.05, revenue of $107.2M beats by $0.53M
https://seekingalpha.com/news/4060915-accuray-gaap-eps-of-0_10-misses-0_05-revenue-of-107_2m-beats-0_53m
• Accuray press release (NASDAQ:ARAY): Q2 GAAP EPS of -$0.10 misses by $0.05.
• Revenue of $107.2M (-6.6% Y/Y) beats by $0.53M.
• The company is reaffirming guidance for fiscal year 2024 as follows:
• Total revenue is expected in the range of $460 million to $470 million, vs. consensus of $463.17M, representing a year-over-year growth range of 3 to 5 percent.
• Adjusted EBITDA for fiscal year 2024 is expected in the range of $27 million to $30 million.
Summer.76,
13. Feb 17:30 Uhr
0
Roth/MKM sets $9 stock target on Accuray, bullish on market expansion
https://m.uk.investing.com/news/stock-market-news/rothmkm-sets-9-stock-target-on-accuray-bullish-on-market-expansion-93CH-3335248
Summer.76,
21. Feb 16:39 Uhr
0
https://www.nasdaq.com/articles/three-reasons-to-retain-accuray-aray-stock-in-your-portfolio
Summer.76,
07.11.2023 22:08 Uhr
0
Accuray Reports Fiscal 2024 First Quarter Financial Results
https://investors.accuray.com/news-releases/news-release-details/accuray-reports-fiscal-2024-first-quarter-financial-results
Company Achieves 8% Revenue Growth, Reiterates FY 2024 Guidance
Summer.76,
26.10.2023 18:56 Uhr
0
https://www.massdevice.com/accuray-lays-off-nearly-6-of-global-workforce/
Summer.76,
04.10.2023 16:33 Uhr
0
Accuray (ARAY) Positioned for Growth: Buy Rating Supported by Chinese Market Expansion, New Product Launches, and Strong Financial Projections
https://markets.businessinsider.com/news/stocks/accuray-aray-positioned-for-growth-buy-rating-supported-by-chinese-market-expansion-new-product-launches-and-strong-financial-projections-1032677267
Summer.76,
04.10.2023 16:31 Uhr
0
https://www.benzinga.com/pressreleases/23/10/n35072403/accuray-announces-approval-of-the-tomo-c-radiation-treatment-delivery-system-by-chinas-national-me
Summer.76,
02.10.2023 14:02 Uhr
0
Accuray and Limbus AI Unveil Online Adaptive Therapy Solution for the Radixact® System at American Society for Radiation Oncology (ASTRO) Annual Meeting
https://investors.accuray.com/news-releases/news-release-details/accuray-and-limbus-ai-unveil-online-adaptive-therapy-solution
...Cenos is designed to enable medical care teams to quickly and efficiently make adjustments, if necessary, to a treatment plan while the patient is still on the treatment table. ...
Summer.76,
15.08.2023 19:39 Uhr
0
https://finance.yahoo.com/news/accurays-aray-treatment-options-boosted-133000149.html
Summer.76,
10.08.2023 5:35 Uhr
0
Accuray Receives FDA Clearance for VitalHold™ on the Radixact® System; Breast Cancer Treatment Option Will Also Be Available in the EU Market
https://www.prnewswire.com/news-releases/accuray-receives-fda-clearance-for-vitalhold-on-the-radixact-system-breast-cancer-treatment-option-will-also-be-available-in-the-eu-market-301895530.html
Summer.76,
09.08.2023 22:30 Uhr
0
Accuray GAAP EPS of -$0.03 misses by $0.04, revenue of $118.3M misses by $3.44M
https://seekingalpha.com/news/4000416-accuray-gaap-eps-of-0_03-misses-0_04-revenue-of-118_3m-misses-3_44m
• Accuray press release (NASDAQ:ARAY): Q4 GAAP EPS of -$0.03 misses by $0.04.
• Revenue of $118.3M (+7.5% Y/Y) misses by $3.44M.
• The Company is introducing guidance for fiscal year 2024 as follows:
• Total revenue is expected in the range of $460 million to $470 million vs $451.05M consensus, representing a year-over-year growth range of 3% to 5%.
• Adjusted EBITDA is expected in the range of $27 million to $30 million.
Summer.76,
09.08.2023 22:11 Uhr
1
Accuray Reports Fourth Quarter and Fiscal 2023 Financial Results
https://www.prnewswire.com/news-releases/accuray-reports-fourth-quarter-and-fiscal-2023-financial-results-301896647.html
8% Q4 revenue growth; Record shipments for FY23; Company issues guidance for FY24
Meistdiskutiert
|
Thema | ||
---|---|---|---|
1 | BED BATH & BEYOND Hauptdiskussion | -28,27 % | |
2 | GAMESTOP Hauptdiskussion | +0,01 % | |
3 | für alle, die es ehrlich meinen beim Traden. | ||
4 | Hexagon Purus | +0,17 % | |
5 | Nio für normale Kommunikation | ±0,00 % | |
6 | RHEINMETALL Hauptdiskussion | +0,08 % | |
7 | Mercedes-Benz Group Hauptdiskussion | ±0,00 % | |
8 | PAYPAL Hauptdiskussion | ±0,00 % | |
9 | Stem Inc. | ±0,00 % | |
10 | Brainchip Klassengruppe | ±0,00 % | Alle Diskussionen |
Anzeige
Aktien
|
Thema | ||
---|---|---|---|
1 | BED BATH & BEYOND Hauptdiskussion | -28,27 % | |
2 | GAMESTOP Hauptdiskussion | +0,01 % | |
3 | Hexagon Purus | +0,17 % | |
4 | Nio für normale Kommunikation | ±0,00 % | |
5 | RHEINMETALL Hauptdiskussion | +0,08 % | |
6 | Mercedes-Benz Group Hauptdiskussion | ±0,00 % | |
7 | PAYPAL Hauptdiskussion | ±0,00 % | |
8 | Stem Inc. | ±0,00 % | |
9 | Brainchip Klassengruppe | ±0,00 % | |
10 | Jaguar Health für Investierte und Interessierte | ±0,00 % | Alle Diskussionen |